CAPRon logo

Capricor Therapeutics Inc (CAPR)

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
CAPR
ISIN Code
US14070B3096
Currency
US Dollar (USD)
IPO Date
2007-02-13

Contact Information

Company Address
10865 Road to the Cure, San Diego, CA, United States, 92121
Contact Phone
858 727 1755
Company Website
https://www.capricor.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-31.23%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99